14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0010 $0.0045 Tuesday, 23rd Apr 2024 PPCB stock ended at $0.0012. This is 9.09% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 20.00% from a day low at $0.0010 to a day high of $0.0012.
90 days $0.0010 $0.0082
52 weeks $0.0001 $0.263

Historical Propanc Biopharma Inc prices

Date Open High Low Close Volume
Apr 23, 2024 $0.0012 $0.0012 $0.0010 $0.0012 1 610 545
Apr 22, 2024 $0.0011 $0.0015 $0.0010 $0.0011 12 454 791
Apr 19, 2024 $0.0011 $0.0013 $0.0010 $0.0011 5 550 947
Apr 18, 2024 $0.0014 $0.0014 $0.0010 $0.0010 11 368 010
Apr 17, 2024 $0.0014 $0.0015 $0.0013 $0.0014 2 581 996
Apr 16, 2024 $0.0014 $0.0016 $0.0013 $0.0013 6 326 497
Apr 15, 2024 $0.0017 $0.0017 $0.0011 $0.0014 13 330 299
Apr 12, 2024 $0.0017 $0.0018 $0.0015 $0.0017 880 101
Apr 11, 2024 $0.0020 $0.0020 $0.0015 $0.0017 1 185 000
Apr 10, 2024 $0.0020 $0.0023 $0.0016 $0.0020 1 933 570
Apr 09, 2024 $0.0014 $0.0020 $0.0013 $0.0020 2 239 535
Apr 08, 2024 $0.0015 $0.0015 $0.0013 $0.0015 5 047 684
Apr 05, 2024 $0.0020 $0.0020 $0.0013 $0.0016 3 693 457
Apr 04, 2024 $0.0022 $0.0022 $0.0012 $0.0020 12 276 464
Apr 03, 2024 $0.0023 $0.0023 $0.0016 $0.0021 5 216 518
Apr 02, 2024 $0.0023 $0.0026 $0.0021 $0.0023 3 216 665
Apr 01, 2024 $0.0032 $0.0032 $0.0020 $0.0023 5 858 725
Mar 28, 2024 $0.0045 $0.0045 $0.0025 $0.0032 11 376 478
Mar 27, 2024 $0.0027 $0.0045 $0.0027 $0.0039 6 470 142
Mar 26, 2024 $0.0028 $0.0028 $0.0022 $0.0027 6 455 552
Mar 25, 2024 $0.0032 $0.0033 $0.0026 $0.0028 2 678 258
Mar 22, 2024 $0.0032 $0.0032 $0.0025 $0.0031 6 532 645
Mar 21, 2024 $0.0029 $0.0030 $0.0029 $0.0030 1 377 314
Mar 20, 2024 $0.0031 $0.0032 $0.0025 $0.0030 1 706 600
Mar 19, 2024 $0.0028 $0.0033 $0.0024 $0.0031 6 270 942
Click to get the best stock tips daily for free!

About Propanc Biopharma Inc

Propanc Biopharma Propanc Biopharma, Inc., a biopharmaceutical company, focuses on the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes acting synergistically. The company has a research collaboration with University of Jaén to commence the POP1 joint drug disc... PPCB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT